CERN has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
CERN has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companyยs financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 5.286 |
CERN's Cash to Debt is ranked higher than
59% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 7.41 vs. CERN: 5.286 ) |
CERN'
s 10-Year Cash to Debt Range
Min: 0.76 Max: 6.16 Current: 5.29 |
| Equity to Asset | 0.765 |
CERN's Equity to Asset is ranked higher than
83% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 0.56 vs. CERN: 0.765 ) |
CERN'
s 10-Year Equity to Asset Range
Min: 0.55 Max: 0.79 Current: 0.77 |
| Interest Coverage | No Debt |
CERN's Interest Coverage is ranked higher than
83% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 25.60 vs. CERN: No Debt ) |
CERN'
s 10-Year Interest Coverage Range
Min: 11 Max: No Debt Current: No Debt |
| F-Score: 5 |
|
| Z-Score: 14.17 |
|
| M-Score: -3.14 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ยย3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 21.40 |
CERN's Operating margin (%) is ranked higher than
92% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 4.30 vs. CERN: 21.40 ) |
CERN'
s 10-Year Operating margin (%) Range
Min: -5.6 Max: 21.4 Current: 21.4 |
| Net-margin (%) | 14.9 |
CERN's Net-margin (%) is ranked higher than
89% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 2.70 vs. CERN: 14.9 ) |
CERN'
s 10-Year Net-margin (%) Range
Min: -7.8 Max: 27.8 Current: 14.9 |
| ROE (%) | 14 |
CERN's ROE (%) is ranked higher than
86% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 4.70 vs. CERN: 14 ) |
CERN'
s 10-Year ROE (%) Range
Min: -10.7 Max: 30.6 Current: 14 |
| ROA (%) | 10.7 |
CERN's ROA (%) is ranked higher than
90% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 2.90 vs. CERN: 10.7 ) |
CERN'
s 10-Year ROA (%) Range
Min: -5.9 Max: 17.1 Current: 10.7 |
| ROC (Joel Greenblatt) (%) | 71.20 |
CERN's ROC (Joel Greenblatt) (%) is ranked higher than
87% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 0.00 vs. CERN: 71.20 ) |
CERN'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -10.3 Max: 71.2 Current: 71.2 |
| Revenue Growth (%) | 11.1 |
CERN's Revenue Growth (%) is ranked higher than
89% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 0.00 vs. CERN: 11.1 ) |
CERN'
s 10-Year Revenue Growth (%) Range
Min: 4.3 Max: 21.5 Current: 11.1 |
| EBITDA Growth (%) | 12 |
CERN's EBITDA Growth (%) is ranked higher than
90% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 0.00 vs. CERN: 12 ) |
CERN'
s 10-Year EBITDA Growth (%) Range
Min: 9.5 Max: 73.6 Current: 12 |
| EPS Growth (%) | 18.3 |
CERN's EPS Growth (%) is ranked higher than
93% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 0.00 vs. CERN: 18.3 ) |
CERN'
s 10-Year EPS Growth (%) Range
Min: -20.5 Max: 22.8 Current: 18.3 |
| Paul Tudor Jones 800 sh (New) Jim Simons 990,752 sh (+27.47%) Frank Sands 4,650,318 sh (+17.78%) | Paul Tudor Jones 100,000 sh (unchged) Vanguard Health Care Fund 5,800,000 sh (unchged) | Ray Dalio Sold Out Ron Baron 613,355 sh (-0.45%) Meridian Funds 509,480 sh (-2.58%) Jeremy Grantham 128,400 sh (-18.84%) RS Investment Management 33,480 sh (-25.86%) Manning & Napier Advisors, Inc 4,116,493 sh (-37.01%) PRIMECAP Management 10,500 sh (-74.07%) Steven Cohen 12,430 sh (-85.58%) |
| Paul Tudor Jones 7,600 sh (+850%) Frank Sands 8,054,102 sh (+73.19%) Meridian Funds 692,710 sh (+35.96%) Manning & Napier Advisors, Inc 4,387,783 sh (+6.59%) Jim Simons 1,013,452 sh (+2.29%) Jeremy Grantham 128,700 sh (+0.23%) | PRIMECAP Management 10,500 sh (unchged) Paul Tudor Jones 100,000 sh (unchged) | Vanguard Health Care Fund 5,700,000 sh (-1.72%) Ron Baron 589,595 sh (-3.87%) RS Investment Management 31,480 sh (-5.97%) Steven Cohen 7,322 sh (-41.09%) |
| Frank Sands 9,374,174 sh (+16.39%) RS Investment Management 32,480 sh (+3.18%) | PRIMECAP Management 10,500 sh (unchged) Vanguard Health Care Fund 5,600,000 sh (unchged) Jeremy Grantham 115,600 sh (unchged) | Steven Cohen Sold Out Paul Tudor Jones Sold Out Vanguard Health Care Fund 5,600,000 sh (-1.75%) Manning & Napier Advisors, Inc 4,202,633 sh (-4.22%) Meridian Funds 560,100 sh (-19.14%) Ron Baron 260,291 sh (-55.85%) Jim Simons 154,900 sh (-84.72%) |
| Ray Dalio 9,100 sh (New) Steven Cohen 4,421 sh (New) Frank Sands 10,063,003 sh (+7.35%) | PRIMECAP Management 10,500 sh (unchged) | Jim Simons Sold Out Manning & Napier Advisors, Inc 4,093,598 sh (-2.59%) RS Investment Management 31,600 sh (-2.71%) Vanguard Health Care Fund 5,382,600 sh (-3.88%) Meridian Funds 500,000 sh (-10.73%) Jeremy Grantham 101,160 sh (-12.49%) Ron Baron 210,219 sh (-19.24%) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Frank Sands | 2013-03-31 | Add 7.35% | 0.23% | $77.51 - $94.74 | $ 99.01 | 14% | 10063003 | |
| Ray Dalio | 2013-03-31 | New Buy | 0.01% | $77.51 - $94.74 | $ 99.01 | 14% | 9100 | |
| Frank Sands | 2012-12-31 | Add 16.39% | 0.41% | $68 - $81.12 | $ 99.01 | 29% | 9374174 | |
| Ron Baron | 2012-12-31 | Reduce -55.85% | 0.16% | $68 - $81.12 | $ 99.01 | 29% | 260291 | |
| Frank Sands | 2012-09-30 | Add 73.19% | 1.1% | $71.03 - $83.56 | $ 99.01 | 32% | 8054102 | |
| Meridian Funds | 2012-09-30 | Add 35.96% | 0.5% | $71.03 - $83.56 | $ 99.01 | 32% | 692710 | |
| Frank Sands | 2012-06-30 | Add 17.78% | 0.26% | $72.77 - $86.72 | $ 99.01 | 27% | 4650318 | |
| Ray Dalio | 2012-06-30 | Sold Out | 0.0038% | $72.77 - $86.72 | $ 99.01 | 27% | 0 | |
| PRIMECAP Management | 2012-06-30 | Reduce -74.07% | $72.77 - $86.72 | $ 99.01 | 27% | 10500 | ||
| Ray Dalio | 2012-03-31 | New Buy | $59.78 - $78.13 | $ 99.01 | 54% | 3195 | ||
| Ron Baron | 2011-12-31 | Add 28.18% | 0.05% | $56.35 - $69.97 | $ 99.01 | 57% | 551088 | |
| Ron Baron | 2011-09-30 | Add 21.24% | 0.04% | $54.93 - $72.88 | $ 99.01 | 54% | 429920 | |
| PRIMECAP Management | 2011-09-30 | Reduce -74.49% | 0.01% | $54.93 - $72.88 | $ 99.01 | 54% | 50000 | |
| PRIMECAP Management | 2011-06-30 | Reduce -88.05% | 0.11% | $54.455 - $62.1 | $ 99.01 | 70% | 196000 | |
| Ron Baron | 2010-12-31 | New Buy | 0.1% | $42.36 - $48.51 | $ 99.01 | 122% | 176000 | |
| PRIMECAP Management | 2010-09-30 | Reduce -31.9% | 0.04% | $36.43 - $41.26 | $ 99.01 | 156% | 865831 | |
| Meridian Funds | 2010-06-30 | Add 11.84% | 0.11% | $38 - $45.79 | $ 99.01 | 136% | 304721 | |
| George Soros | 2010-06-30 | Sold Out | 0.01% | $38 - $45.79 | $ 99.01 | 136% | 0 |
More recent guru trades are included for Premium Members only!!| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 42.00 |
CERN's P/E(ttm) is ranked lower than
57% of the 1023 Companies in the Global Health Information Services industry. ( Industry Median: 20.80 vs. CERN: 42.00 ) |
CERN'
s 10-Year P/E(ttm) Range
Min: 11.39 Max: 50.95 Current: 42 |
| P/B | 6.00 |
CERN's P/B is ranked lower than
69% of the 1370 Companies in the Global Health Information Services industry. ( Industry Median: 2.02 vs. CERN: 6.00 ) |
CERN'
s 10-Year P/B Range
Min: 1.4 Max: 6.5 Current: 6 |
| P/S | 6.45 |
CERN's P/S is ranked lower than
68% of the 1452 Companies in the Global Health Information Services industry. ( Industry Median: 1.69 vs. CERN: 6.45 ) |
CERN'
s 10-Year P/S Range
Min: 0.82 Max: 6.47 Current: 6.45 |
| PFCF | 43.90 |
CERN's PFCF is ranked lower than
61% of the 1019 Companies in the Global Health Information Services industry. ( Industry Median: 17.43 vs. CERN: 43.90 ) |
CERN'
s 10-Year PFCF Range
Min: 13.25 Max: 2862.5 Current: 43.9 |
| EV-to-EBIT | 27 |
CERN's EV-to-EBIT is ranked lower than
56% of the 1019 Companies in the Global Health Information Services industry. ( Industry Median: 14.50 vs. CERN: 27 ) |
CERN'
s 10-Year EV-to-EBIT Range
Min: 7.7 Max: 325 Current: 27 |
| PEG | 2.9 |
CERN's PEG is ranked higher than
52% of the 423 Companies in the Global Health Information Services industry. ( Industry Median: 1.64 vs. CERN: 2.9 ) |
CERN'
s 10-Year PEG Range
Min: 0.57 Max: 2.9 Current: 2.9 |
| Shiller P/E | 63.8 |
CERN's Shiller P/E is ranked lower than
100% of the Companies in the Global Health Information Services industry. ( Industry Median: vs. CERN: 63.8 ) |
CERN'
s 10-Year Shiller P/E Range
Min: 25.16 Max: 87.66 Current: 63.8 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Cash | 103.1 |
CERN's Price/Net Cash is ranked lower than
77% of the 465 Companies in the Global Health Information Services industry. ( Industry Median: 9.10 vs. CERN: 103.1 ) |
CERN'
s 10-Year Price/Net Cash Range
Min: 82.5 Max: 152.8 Current: 103.1 |
| Price/Net Current Asset Value | 38.2 |
CERN's Price/Net Current Asset Value is ranked lower than
61% of the 930 Companies in the Global Health Information Services industry. ( Industry Median: 13.40 vs. CERN: 38.2 ) |
CERN'
s 10-Year Price/Net Current Asset Value Range
Min: 5.6 Max: 30.5 Current: 38.2 |
| Price/Tangible Book | 7.8 |
CERN's Price/Tangible Book is ranked lower than
63% of the 1116 Companies in the Global Health Information Services industry. ( Industry Median: 3.30 vs. CERN: 7.8 ) |
CERN'
s 10-Year Price/Tangible Book Range
Min: 3.1 Max: 6.8 Current: 7.8 |
| Price/DCF (Projected) | 3 | ||
| Price/Median PS Value | 2.1 |
CERN's Price/Median PS Value is ranked lower than
68% of the 1300 Companies in the Global Health Information Services industry. ( Industry Median: 1.00 vs. CERN: 2.1 ) |
CERN'
s 10-Year Price/Median PS Value Range
Min: 0.5 Max: 1.7 Current: 2.1 |
| Price/Peter Lynch Fair Value | 2.8 |
CERN's Price/Peter Lynch Fair Value is ranked higher than
50% of the 276 Companies in the Global Health Information Services industry. ( Industry Median: 1.50 vs. CERN: 2.8 ) |
CERN'
s 10-Year Price/Peter Lynch Fair Value Range
Min: 1 Max: 2.3 Current: 2.8 |
| Price/Graham Number | 3.9 |
CERN's Price/Graham Number is ranked lower than
66% of the 813 Companies in the Global Health Information Services industry. ( Industry Median: 1.80 vs. CERN: 3.9 ) |
CERN'
s 10-Year Price/Graham Number Range
Min: 1.6 Max: 3.4 Current: 3.9 |
| Earnings Yield (Greenblatt) | 3.70 |
CERN's Earnings Yield (Greenblatt) is ranked higher than
64% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 3.30 vs. CERN: 3.70 ) |
CERN'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.3 Max: 13 Current: 3.7 |
| Forward Rate of Return (Yacktman) | 16.2 |
CERN's Forward Rate of Return (Yacktman) is ranked higher than
92% of the 1618 Companies in the Global Health Information Services industry. ( Industry Median: 0.00 vs. CERN: 16.2 ) |
CERN'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0.5 Max: 62.5 Current: 16.2 |
| Industry: | Health Information Services | |
|---|---|---|
| Compare: | CTRX, ATHN, MDRX, AH, QSII | |
| Traded in other countries: | CRE.Germany |
| This Is What Real Bubbles Look Like May 29 2013 |
| comment on CERN Feb 18 2013 |
| 4 Big Cap Stocks That Are Thriving Oct 31 2012 |
| Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 |
| HealthStream: A Solid Long-Term Play Apr 19 2012 |
| Weekly Top Insider Sells: CVS, DELL, CERN, FIS, and CXO Mar 19 2012 |
| Strong S Feb 04 2012 |
| 52-Week High Companies: GMCR, TJX, MICC, AMZN, CERN Aug 01 2011 |
| Cerner Corp. (CERN) Exec. VP & COO Mike Valentine sells 7,000 Shares Mar 15 2011 |
| Cerner Corp. (CERN) Chairman, CEO & President Neal L Patterson sells 2,000 Shares Mar 15 2011 |
| Quality Systems in EHR Association - Analyst Blog Jun 18 2013 - ZACKS |